Anthony Pajot

Title: Anthony Pajot: Innovator in Transgenic Research

Introduction

Anthony Pajot is a notable inventor based in Paris, France. He has made significant contributions to the field of transgenic research, particularly in the development of mice with human major histocompatibility complex (MHC) phenotypes. His work has implications for experimental uses and applications in medical research.

Latest Patents

Anthony Pajot holds 2 patents. His latest patents focus on transgenic mice that possess a disrupted H2 class I gene and a disrupted H2 class II gene. These mice also include functional HLA class I and class II transgenes. The invention details methods of using these transgenic mice, which are deficient in both H2 class I and class II molecules, making them valuable for various experimental applications.

Career Highlights

Throughout his career, Anthony Pajot has worked with prestigious institutions such as Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. His research has contributed to advancements in understanding immune responses and the development of therapeutic strategies.

Collaborations

Anthony has collaborated with notable colleagues, including Yu-Chun Lone and Claude Auriault. Their combined expertise has furthered the impact of his research in the scientific community.

Conclusion

Anthony Pajot's innovative work in transgenic research highlights his role as a key inventor in the field. His contributions continue to influence medical research and the development of new therapeutic approaches.